It has been shown that inflammatory cytokines were essential factors contributing to NAFLD and could be used as biomarkers to evaluate the development of disease and predict prognosis, such as interleukin (IL)-1β, IL-6, tumor necrosis factor-α (TNF-α) (19, 20). Here, IL1B is linked to metabolic dysfunction-associated steatotic liver disease.